# V1 Empirics Check — openai/gpt-5.4 (Variant B)

**Model:** openai/gpt-5.4
**Variant:** B
**Date:** 2026-03-22T14:40:06.491034

---

## 1. Idea Fidelity

The paper clearly pursues the broad original idea: using staggered GP practice “closures” from ODS and A&E utilization data to study whether loss of primary care access increases emergency care use. It also follows the intended empirical template in spirit by exploiting staggered timing and reporting a Callaway-Sant’Anna estimator alongside event-study evidence.

That said, it departs from the strongest version of the original design in several important ways. First, the manifest envisioned a local-area design with mechanisms using practice-level registrations, appointments, and workforce; the paper instead aggregates treatment to the trust level via proximity to the nearest acute trust and does not implement the proposed mechanisms. Second, the manifest’s core empirical object was the effect of genuine primary-care access loss, but the paper’s own narrative makes clear that the ODS “closure” measure is heavily contaminated by mergers and administrative code retirements. Third, because the treatment is assigned to trusts based on any closure within a 15 km radius, the design is much coarser than the original idea suggested and may not correspond well to the patient catchment through which causal effects would operate.

## 2. Summary

This paper asks an important policy question: whether GP practice closures in England increase major A&E attendance. Using ODS inactive-practice records and provider-level A&E data in a staggered DiD framework, the paper finds a robust null and interprets this as evidence that primary care consolidation has not, on average, generated the feared emergency-department externality. The question is worthwhile and the data assembly is promising, but in its current form the paper does not convincingly identify the causal effect of meaningful reductions in primary-care access.

## 3. Essential Points

1. **Treatment is not credibly measuring the policy-relevant shock.**  
   The paper’s central threat is not just attenuation; it undermines the interpretation of the estimand. The authors show that 75% of “closures” occur in 2023 and plausibly reflect administrative cleanup after NHS reorganization. If the treatment largely captures code retirement, mergers, or relabeling rather than real site closures or meaningful access loss, then the paper cannot support the headline claim about the effect of GP practice closures on A&E use. At minimum, the authors need to construct a validated subset of genuine closures/access shocks using auxiliary data (patient list disappearance/reallocation, site-level continuity, successor-practice mapping, workforce changes, or manual validation for a sizable sample).

2. **The unit of analysis and treatment mapping are poorly aligned with the causal channel.**  
   A closure is a highly local event, while the outcome is trust-level quarterly A&E attendance. Assigning treatment when any closure occurs within 15 km of the trust postcode is difficult to interpret and likely induces severe exposure mismeasurement, especially in urban areas with overlapping catchments and multiple hospitals. The paper needs a more defensible spatial design: e.g., area-level outcomes, patient catchment weighting, exposure based on affected registered patients rather than any closure, or at least treatment intensity weighted by distance and pre-closure list size.

3. **The null is overstated as “precise” given the design and data limitations.**  
   The paper repeatedly claims to rule out substantively important effects, but that is not established. The comparison is between treated and never-treated trusts that differ dramatically in size and urbanicity; the event study is estimated in TWFE despite staggered timing; and the CS estimate is much less precise than the headline TWFE result. Given treatment contamination and aggregation, the current estimates are better interpreted as showing no detectable effect of this administrative treatment proxy on trust-level A&E volumes—not no effect of real GP closures on emergency care. The framing and conclusions need to be narrowed substantially unless the identification is strengthened.

## 4. Suggestions

This is a good topic with clear policy relevance, and the paper could become useful if it is reframed and the measurement is improved. My suggestions are mostly about sharpening the estimand and aligning the data with the mechanism.

First, I would strongly encourage the authors to **rebuild the treatment variable around genuine access loss rather than ODS inactivity per se**. The paper already contains the seeds of this point, but currently uses that diagnosis to explain away the null rather than to improve the design. Some feasible approaches:
- Link inactive practices to **monthly patient registrations** and define a true closure as one with a sharp drop to zero and no immediate successor code at the same address.
- Use **practice postcode/address continuity** to distinguish mergers/re-codings from physical site disappearance.
- Examine **GP workforce** and **appointments** in nearby surviving practices to identify whether local capacity actually changed after the event.
- Construct an “affected patients” measure: the practice’s last observed list size, perhaps net of patients transferred to a same-site successor. This would be far more meaningful than a binary “any closure within 15 km.”

Second, the paper would benefit from a **more local outcome geography**. Trust-level A&E attendance is an awkward match because a single trust serves many neighborhoods and many closures. If the data permit, a more compelling design would use local authority, MSOA/LSOA, or ICB-place outcomes; if not, the authors should at least create trust exposure based on the share of the trust’s surrounding population or GP-registered patients affected by closures. As written, a tiny practice closure and a large multi-thousand-patient closure both trigger the same treatment indicator.

Relatedly, the geographic mapping needs much more justification. Why the **trust postcode** as the anchor? Why the **nearest A&E trust** or a **15 km radius**? Patients do not choose emergency care based on trust headquarters, and GP catchments are not circles around hospital postcodes. I would suggest:
- weighting closures by inverse distance to all nearby Type 1 A&E sites;
- using hospital-site postcodes rather than trust administrative postcodes;
- validating the mapping against known patient flows if possible;
- reporting how many closures are linked to multiple trusts under plausible alternative rules.

Third, the paper should make much more of the **heterogeneity in event quality**. Averages over thousands of dubious closures are not the most informative object. A stronger paper would separate:
- pre-2023 vs. 2023+ events;
- events with large disappearing patient lists vs. administrative-only events;
- urban vs. rural closures;
- closures in areas with low baseline GP density or high deprivation;
- closures where the nearest alternative GP is materially farther away.

These heterogeneity analyses are not just “nice to have”; they would help determine whether the average null hides effects in the settings where access shocks are actually meaningful.

Fourth, the proposed **mechanism tests from the manifest should be brought back into the paper**. If closures truly do not reduce access, surviving practices should absorb patients and appointments without notable dilution. If closures do reduce access, one might see:
- increased registered patients at nearby surviving practices,
- reduced appointments per patient,
- lower GP FTE per 1,000 patients,
- potentially increased urgent-care use.  
Even if the main A&E effect remains null, these mechanism results would make the paper much more informative and would help distinguish “no access shock” from “access shock with no hospital spillover.”

Fifth, the event-study analysis should be improved. Since the paper itself acknowledges staggered treatment and reports a CS estimator, the dynamic analysis should also be based on a **heterogeneity-robust event-study estimator**, not only TWFE leads and lags. The current pre-trend evidence is not fully reassuring because the treatment is highly concentrated in a few periods and because treated and never-treated trusts are very different. I would also like to see:
- cohort-specific timing distributions,
- support by event time,
- share of observations contributing to each lead/lag,
- plots rather than only a table,
- and a discussion of what post-periods are actually identified given the 2023 spike.

Sixth, the paper should revisit its handling of **standard errors and inference**. With 261 trusts, clustering at trust level is standard, but given common national shocks in A&E demand and possible spatial correlation, some robustness using wild bootstrap or alternative clustering/spatial corrections would be welcome. The COVID period is also not a minor nuisance here; it is a large structural break in both primary and emergency care utilization. More flexible time effects or separate trend controls by region/urbanicity may be warranted.

Seventh, I would encourage a more careful **discussion of statistical power and effect magnitudes**. The current prose overclaims precision. A null in trust-level aggregate volumes may still be consistent with meaningful patient-level disruption if affected practices are small relative to trust catchments or if treatment is mismeasured. The paper should distinguish between:
- effects on total major A&E volumes,
- effects on specific categories of potentially GP-substitutable attendances,
- and effects on a relatively small subset of displaced patients.  
If possible, outcomes closer to substitution behavior—such as ambulance-free/self-referred attendances, same-day urgent care, or minor/emergency presentations—might be more responsive than total Type 1 attendance.

Eighth, the “placebo” using total attendances is not especially persuasive as currently framed. Total attendances are not a placebo in the usual sense; they are another plausible outcome that may be affected. A better placebo would be an outcome that should not respond to GP access shocks, such as attendances for clearly non-deferrable emergencies, or pre-period pseudo-treatment dates.

Ninth, the sample description needs tightening. There are small internal inconsistencies (e.g., 154 treated + 105 never-treated does not equal 261; the quarter notation in the summary table is odd), and the paper should be more transparent about:
- which trusts enter the sample and why,
- whether trust mergers/reorganizations occurred,
- how Type 1 A&E sites are identified within multi-site trusts,
- and how missing monthly files or coding changes are handled.

Finally, I think the paper would improve by **reframing its contribution modestly**. In its present state, the strongest defensible claim is not “the gatekeeper deficit wasn’t” but something closer to: *administrative GP deactivation events in ODS are a poor proxy for true primary-care access shocks, and when used as such they show no detectable relationship with trust-level A&E volumes.* That is still potentially publishable if executed carefully, because it is an important measurement lesson. But to make a causal contribution about policy-relevant closures, the authors need to isolate real closures and show that the treatment corresponds to actual reductions in local primary-care capacity.
